Kyverna Therapeutics Inc (NASDAQ: KYTX) is -57.62% lower on its value in year-to-date trading and has touched a low of $1.78 and a high of $11.40 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The KYTX stock was last observed hovering at around $3.47 in the last trading session, with the day’s gains setting it 344.34%.
Currently trading at $347.81K, the stock is 4.91% and 27.80% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.71 million and changing 3712092% at the moment leaves the stock -9.89% off its SMA200. KYTX registered -12.30% loss for a year compared to 6-month loss of -16.33%. The firm has a 50-day simple moving average (SMA 50) of $2.5666 and a 200-day simple moving average (SMA200) of $3.639925.
The stock witnessed a 28.63% gain in the last 1 month and extending the period to 3 months gives it a 39.28%, and is 6.84% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.67% over the week and 10.57% over the month.
Kyverna Therapeutics Inc (KYTX) has around 112 employees, a market worth around $141.76M and $0.00M in sales. Distance from 52-week low is 84.27% and -71.23% from its 52-week high. The company has generated returns on investments over the last 12 months (-63.96%).
The EPS is expected to shrink by -11.70% this year.
Kyverna Therapeutics Inc (KYTX) Top Institutional Holders
127.0 institutions hold shares in Kyverna Therapeutics Inc (KYTX), with institutional investors hold 77.86% of the company’s shares. The shares outstanding are 43.22M, and float is at 19.45M with Short Float at 10.79%. Institutions hold 68.49% of the Float.
The top institutional shareholder in the company is VIDA VENTURES ADVISORS, LLC with over 4.52 million shares valued at $33.93 million. The investor’s holdings represent 10.4901% of the KYTX Shares outstanding. As of 2024-06-30, the second largest holder is BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC with 3.37 million shares valued at $25.26 million to account for 7.8106 of the shares outstanding. The other top investors are NORTHPOND VENTURES, LLC which holds 3.26 million shares representing 7.5487% and valued at over $24.42 million, while JPMORGAN CHASE & CO holds 4.7796 of the shares totaling 2.06 million with a market value of $15.46 million.
